MCUJF vs PYRGF
Medicure Inc. and PyroGenesis Canada Inc., side by side — 4 fiscal years reported in CAD, drawn from SEC filings.
Most recent reported year
| Metric | MCUJF | PYRGF |
|---|---|---|
| Revenue | CAD 21.9M | CAD 19.0M |
| Net income | CAD -1.0M | CAD -32.2M |
| Gross margin | 59.7% | 42.8% |
| Net margin | −4.7% | −169.2% |
| Return on equity | −5.1% | −111.6% |
| Diluted EPS | −CAD 0.10 | −CAD 0.19 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | CAD 638,000 | CAD -11.5M |
| Equity | · | · |
| Net debt / equity | · | −0.18× |
| Current ratio | 1.89× | 1.06× |
| Revenue CAGR 5y | 1.7% | · |
| Profit CAGR 5y | · | · |
MCUJF bills 1.2× the revenue of PYRGF, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
4 years side by side
| Fiscal year | MCUJF | PYRGF |
|---|---|---|
| FY2022 | CAD 23.1M | CAD 19.0M |
| FY2021 | CAD 21.7M | CAD 31.1M |
| FY2020 | CAD 11.6M | CAD 17.8M |
| FY2019 | CAD 20.2M | CAD 4.8M |
Bottom line
| Fiscal year | MCUJF | PYRGF |
|---|---|---|
| FY2022 | CAD 1.4M | CAD -32.2M |
| FY2021 | CAD -727,000 | CAD -38.4M |
| FY2020 | CAD -6.8M | CAD 41.8M |
| FY2019 | CAD -19.8M | CAD -9.2M |
Standard deviation, each side
PYRGF's net margin has been more volatile than MCUJF's over the 4 comparable fiscal years — 173.2 percentage points of standard deviation against 42.4.
4 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between MCUJF and PYRGF over these 4 fiscal years — MCUJF led in 3 and PYRGF in 1.
4 of 10 comparable fiscal years — a year missing data on either side is not counted.